Denali Therapeutics (DNLI) FCF Margin (QoQ) (2018 - 2023)

Denali Therapeutics (DNLI) FCF Margin (QoQ) (2018 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Denali Therapeutics 4.37 Bn 4.37 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2023 -617,431.00
Jun 30, 2023 14,527.00
Mar 31, 2023 53,917.00
Dec 31, 2022 76,942.00
Sep 30, 2022 -139,848.00
Jun 30, 2022 7,665.00
Mar 31, 2022 -1,936.00
Dec 31, 2021 62,818.00
Sep 30, 2021 -43,587.00
Jun 30, 2021 32,519.00
Mar 31, 2021 -83,173.00
Dec 31, 2020 14,891.00
Sep 30, 2020 76,483.00
Jun 30, 2020 10.57 Mn
Sep 30, 2019 18,649.00
Jun 30, 2019 -30,960.00
Mar 31, 2019 -83,143.00
Dec 31, 2018 315,066.00
Sep 30, 2018 -55,472.00
Jun 30, 2018 -772,278.00